Intravascular Catheters Market Size, Share & Trends Report

Intravascular Catheters Market Size, Share & Trends Analysis Report By Product (Short, Integrated/Closed PIVCs), By Application (Gastroenterology, Infectious Disease), By End Use (Hospital, ASC), And Segment Forecasts, 2019 - 2025

  • Published Date: Jan, 2019
  • Base Year for Estimate: 2017
  • Report ID: GVR-2-68038-744-5
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2017
  • Number of Pages: 85

Industry Insights

The global intravascular catheters market size was valued at USD 3.80 billion in 2017 and is anticipated to expand at lucrative CAGR of 11.4% over the forecast period. Key factors attributing to the growth include increasing incidence of Cardiovascular Diseases (CVDs), neurological disorders, Urinary Tract Infections (UTIs). Several other factors driving the growth of this market include rising cases of hospitalizations owing to chronic diseases and increasing number of Ambulatory Care Centers (ASCs) and catheterization labs.

With a rise in the cases of CVDs and urological diseases, there is an increased demand for minimally invasive surgeries, which require the usage of catheters for surgical and diagnostic procedures. Thus, usage of catheters in various minimally invasive diagnostic and interventional procedures is likely to augment the market growth. Furthermore, technological advancements in the field are anticipated to eliminate most of the infection risks associated with intravascular catheters.

U.S. intravascular catheters market

This, in turn, is likely to boost the demand for catheters over the next few years. A number of initiatives undertaken by various governments across the globe to provide medical cover to millions of new patients will also contribute to the industry expansion. In addition, programs, such as Child Health Insurance Program (CHIP) in U.S., which provide 365 day healthcare coverage to children, are anticipated to boost the growth of the market over the forecast period.

Asia Pacific, in particular, led the global market in 2017 due to the factors, such as presence of target population and high investments in healthcare infrastructure. This region is anticipated to witness a lucrative growth in the coming years on account of high potential to capture unmet medical needs for patients suffering from CVDs and trauma injuries. China alone accounted for the largest share of the regional market in 2017 owing to high unmet medical needs, awareness about hospital-acquired infections, and easy healthcare accessibility.

Product Type Insights

Based on the product type, the intravascular catheters markets is classified into short and integrated peripheral intravenous catheters (PIVCs). In 2017, short PVIC segment led the market and is anticipated to expand at the fastest CAGR over the forecast period. This growth can be attributed to the factors, such as added advantage of less catheter infections associated with short PIVCs.

The integrated PIVC segment is also expected to witness a lucrative growth over the forecast period. Increasing incidences of cardiovascular, neurological, oncological, and gastroenterological diseases, are anticipated to drive the segment further. Furthermore, presence of a wide range of intravascular catheters for various interventional procedures is driving demand for these products.

Application Insights

On the basis of application, the market is classified into oncology, gastroenterology, renal disease, infectious diseases, and others. The other applications segment consists of surgical interventions for trauma and other diseases including cardiovascular and urological diseases. In 2017, this segment led the market and is expected to witness a lucrative growth over the forecast period.

The infectious diseases segment is said to expand at the fastest CAGR over the forecast period owing to increasing incidence of infectious diseases, such as HIV, tuberculosis, HPV, and others. For instance, according to Avert, about 36.9 million people were diagnosed with HIV across the globe. Furthermore, according to the World Health Organization (WHO) in 2017, about 10 million people fell ill from tuberculosis and caused about 1.6 million deaths worldwide. Increasing incidence of these diseases has been responsible for growing cases of hospitalizations, which, in turn, is projected to spur the market development.

End-use Insights

On the basis of end use, the market is segmented into hospitals, clinics, ASCs, homecare, others. In 2017, hospitals led the market with a revenue of USD 2.29 billion and is anticipated to expand at a lucrative CAGR over the forecast period. This is mainly due to high prevalence of surgeries requiring catheters in hospitals for the treatment of cardiovascular, gastroenterology, and renal diseases.

The ASCs segment is anticipated to register the fastest CAGR of 13.1% over the forecast period. The ASCs are independent healthcare facilities entirely focused on providing outpatient surgical care. They incur comparatively less surgery costs and are also cleaner and safer than hospitals. These factors, coupled with increasing incidence of cardiovascular, neurological, oncological, and gastroenterological diseases, are anticipated to drive the segment development in the coming years.

Regional Insights

On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Asia Pacific led the market in 2017 and is estimated to grow further at a lucrative CAGR. Some of the key reasons responsible for the high market share of Asia Pacific include growing prevalence of oncological disorders, infectious and renal diseases, urological problems, rising inpatient, and emergency room procedures. Moreover, increasing population is anticipated to drive the regional market further.

Global intravascular catheters market

On the other hand, MEA is expected to record the fastest CAGR of 13.0% over the forecast period. Key factor responsible for this growth are increasing prevalence of CVDs and other anomalies in low- and middle-income countries. Moreover, constantly improving healthcare infrastructure and rise in healthcare expenditure levels coupled with high unmet medical needs are expected to impel the region’s growth.

Intravascular Catheters Market Share Insights

Some of the key companies in this market include Cook Medical, Inc.; Smiths Medical, Inc.; Edwards Life Sciences Corp.; Medtronic PLC; Johnson & Johnson; McKesson Medical Surgical, Inc.; and Terumo Corporation.

Report Scope



Base year for estimation


Actual estimates/Historical data

2014 – 2017

Forecast period

2018 – 2025

Market representation

Revenue in USD Million and CAGR from 2018 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America, and MEA

Country scope

U.S., Canada, Germany, U.K., Japan, China, Mexico, Brazil, and South Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

15% free customization scope (equivalent to 5 analyst working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue and volume growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global intravascular catheters market report on the basis of product, application, end use, and region:

  • Product Outlook (Revenue, USD Million, 2014 - 2025)

    • Short PIVC

    • Integrated/Closed PIVC

  • Application Outlook (Revenue, USD Million, 2014 - 2025)

    • Oncology

    • Gastroenterology

    • Renal Disease

    • Infectious Diseases

    • Others

  • End Use Outlook (Revenue, USD Million, 2014 - 2025)

    • Hospitals

    • Clinics

    • ASC

    • Homecare

    • Others

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Mexico

      • Brazil

    • MEA

      • South Africa

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $4,950
Multi User (2-5) - $5,950
Enterprise Access - $7,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified